Home
About
Capabilities
R&D
Investors
News
Careers
中文
Home
About
Capabilities
R & D
Investors
News
Careers
Press Release
Press Release
2024
2023
2022
2021
2020
2019
2018
2017
Feb 18, 2024
Mabwell Receives IND Approval from FDA for Novel B7-H3 ADC 7MW3711
➞
Jan 31, 2024
Mabwell and Fudan University Shanghai Cancer Center Renew Strategic Cooperation Agreement
➞
Jan 04, 2024
Mabwell Established a Licensing and Commercialization Agreement for MAILISHU Indonesia Market
➞
Jan 02, 2024
Mabwell to attend 42nd JP Morgan Healthcare Conference and present at Biotech Showcase
➞
上一页
1
2
开元体育(中国)官方网站
|
亚搏官方娱乐
|
乐动在线·(中国)官方网站
|
开云app中国官方网站(中国)科技公司
|
爱游戏官网登录
|
华体会官方网站-华体会(中国)
|
韦德官方网站
|
欧宝app官方入口
|
hg8888皇冠
|